Zynex stock gains amid report it’s pursuing strategic options, including a sale


TENS, Transcutaneous Electrical Nerve Stimulation in Physical Therapy.

mladenbalinovac/E+ via Getty Images

Zynex (NASDAQ:ZYXI) rose 2% amid a report that the medical device maker is evaluating its options, including a possible sale.

The company is working with Cantor Fitzgerald to review its options, including a takeover, a merger, a divestiture, a recapitalization, or another transaction, according to a

Source link

Leave A Reply

Your email address will not be published.